S Hope

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis

S Hope, Sophie Wienand-Barnett, Maggie Shepherd et al. · British Journal of General Practice · 2016 · 87 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

Random non‐fasting C–peptide: bringing robust assessment of endogenous insulin secretion to the clinic

S Hope, Bridget Knight, Beverley M. Shields et al. · Diabetic Medicine · 2016 · 66 citations

Medicine, Endocrinology, Clinical Nutrition +14

Are we missing hypoglycaemia? Elderly patients with insulin-treated diabetes present to primary care frequently with non-specific symptoms associated with hypoglycaemia

S Hope, Phil J. Taylor, Beverley M. Shields et al. · Primary care diabetes · 2017 · 47 citations · Full text

Medicine, Endocrinology, Geriatric Medicine +17